Anthony Stonefield
Chief Executive Officer, Co-Founder & Angel Investor
Transformative technology entrepreneur with 28 years venture development experience in the US, UK, Europe, sub-Saharan Africa and the Middle East. Pioneered media distribution over digital networks. Veteran venture developer and author of 11 patents. Built international innovation companies with sales of over USD1.5 billion
Jonathan Lakey, PhD, MSM
Consulting Senior Research Scientist
PhD, MSM: Professor Emeritus at University of California, Irvine. Founding member and former Faculty Scientist at Sue and Bill Gross Stem Cell Research Center. Authored 510 academic papers, 45 book chapters on stem cell applications. Specialty is stem cell implantation scaffolds. Working internationally but primarily in Ottawa and California, Dr. Lakey mentors dozens of MSc. and PhD
student in his research laboratories.
Ignatius Viljoen, IRCA, ICQ Regenerative Medicine GxP and Regulatory Compliance Advisor
Chartered Quality Professional and Qualified Person in cGMP environments. Completing PhD at the University of Pretoria's Institute for Cellular and Molecular Medicine (ICMM), focusing on regulatory compliance for cell-based regenerative medicines. Contributor to the WHO Regulatory Convergence of Cell and Gene Therapy Products initiative
Gert Jordaan, PhD
Applied Research Specialist
PhD: Pioneering applied stem cell researcher with advanced degrees from Oxford University, Princeton University and several other universities in veterinary science, mammalian reproduction and cell biology. Experienced practitioner of Somatic Cell Nuclear Transfer and stem cell manipulation for therapeutic cloning purposes.
Dave Anderson
Non-Exec. Chairman & Investor
Seasoned executive in the pharmaceutical and specialty chemical industries - Ciba-Geigy/Novartis and Rohm & Haas - in the US, UK and South Africa. Led manufacturing and regulatory disciplines in 17 pharmaceutical product launches.